| MCYAX | RNWEX | MCYAX / RNWEX | |
| Total Expense Ratio | 1.50 | 0.92 | 163% |
| Annual Report Gross Expense Ratio | 1.74 | 0.92 | 189% |
| Fund Existence | 9 years | 24 years | - |
| Gain YTD | 26.555 | 13.518 | 196% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 15000 | 250 | 6,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 130M | 90.9B | 0% |
| Annual Yield % from dividends | 0.72 | 0.97 | 75% |
| Returns for 1 year | 44.41 | 20.11 | 221% |
| Returns for 3 years | 85.25 | 46.99 | 181% |
| Returns for 5 years | 26.49 | 13.51 | 196% |
| Returns for 10 years | N/A | 113.76 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYBOX | 75.92 | 2.19 | +2.97% |
| Rydex Biotechnology A | |||
| AMFFX | 64.23 | 0.40 | +0.63% |
| American Funds American Mutual F1 | |||
| ACGQX | 24.66 | 0.07 | +0.28% |
| Invesco Growth and Income R5 | |||
| SMVFX | 12.95 | -0.13 | -0.99% |
| Virtus Ceredex Mid-Cap Value Equity C | |||
| HFCGX | 36.45 | -0.80 | -2.15% |
| Hennessy Cornerstone Growth Investor | |||